NCT01942161 - A Short Treatment Study of Aripiprazole in Pediatric Patients With Schizophrenia | Biotech Hunter

Enrollment

106

Participants

Timeline

Start Date

August 31, 2010

Primary Completion Date

November 30, 2014

Study Completion Date

November 30, 2014

Conditions

Schizophrenia

Interventions

DRUG

Aripiprazole Low (2 mg/day)

administered 2 mg once daily for 6 weeks

DRUG

Aripiprazole Mid (6 - 12 mg/day)

administered 2 mg once daily for 2 days, followed by a maintenance dose of 6 mg for 40 days. From Day 15 onwards, the dose may be increased to 12 mg

DRUG

Aripiprazole High (24 - 30 mg/day)

administered 2, 6, 12, 18 mg sequentially, each dose once daily for 2 days respectively, followed by a maintenance dose of 24 mg for 34 days. From Day 15 onwards, the dose may be increased to 30 mg

Trial Locations (8)

Unknown

Chubu Region

Chugoku Region

Hokkaido Region

Kansai Region

Kanto Region

Kyushu Region

Shikoku Region

Tohoku Region